Cargando…
Pharmaceutical care of rituximab in the treatment of children with refractory anti-NMDAR encephalitis: A case report
Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is a rare disease of nervous system, which is mediated by autoimmune mechanisms. The treatment of anti-NMDAR encephalitis includes Immunotherapy, symptomatic and supportive treatment for seizures and psychiatric symptoms. There are many kinds o...
Autores principales: | Wu, Haiyan, Xu, Xiaoyan, Ding, Qixuan, Zhu, Shuangfei, Zheng, Qiaozhen, Ding, Shanshan, Li, Jiyao, Zhao, Hongyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901968/ https://www.ncbi.nlm.nih.gov/pubmed/36749271 http://dx.doi.org/10.1097/MD.0000000000032843 |
Ejemplares similares
-
Efficacy and Safety of Rituximab in Chinese Children With Refractory Anti-NMDAR Encephalitis
por: Dou, Xiangjun, et al.
Publicado: (2020) -
Medication analysis and pharmaceutical care for a child with Kawasaki disease: A case report and review of the literature
por: Lai, Yingqiang, et al.
Publicado: (2023) -
Rituximab was used to treat recurrent IgG4-related hypophysitis with ophthalmopathy as the initial presentation: A case report and literature review
por: Gu, Wei-Jun, et al.
Publicado: (2017) -
Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis: A case report and literature review
por: Chen, Wei-xun, et al.
Publicado: (2019) -
Evaluation of the effect of pharmaceutical care during inpatient treatment in a department of neurology: A retrospective study
por: Ji, Wen, et al.
Publicado: (2022)